190 related articles for article (PubMed ID: 19276347)
1. E2F1 Induces tumor cell survival via nuclear factor-kappaB-dependent induction of EGR1 transcription in prostate cancer cells.
Zheng C; Ren Z; Wang H; Zhang W; Kalvakolanu DV; Tian Z; Xiao W
Cancer Res; 2009 Mar; 69(6):2324-31. PubMed ID: 19276347
[TBL] [Abstract][Full Text] [Related]
2. MicroRNA-330 acts as tumor suppressor and induces apoptosis of prostate cancer cells through E2F1-mediated suppression of Akt phosphorylation.
Lee KH; Chen YL; Yeh SD; Hsiao M; Lin JT; Goan YG; Lu PJ
Oncogene; 2009 Sep; 28(38):3360-70. PubMed ID: 19597470
[TBL] [Abstract][Full Text] [Related]
3. Transcription factor E2F1 is a potent transactivator of the insulin-like growth factor-I receptor (IGF-IR) gene.
Schayek H; Bentov I; Rotem I; Pasmanik-Chor M; Ginsberg D; Plymate SR; Werner H
Growth Horm IGF Res; 2010 Feb; 20(1):68-72. PubMed ID: 19703789
[TBL] [Abstract][Full Text] [Related]
4. Nucleophosmin/B23 regulates transcriptional activation of E2F1 via modulating the promoter binding of NF-kappaB, E2F1 and pRB.
Lin CY; Liang YC; Yung BY
Cell Signal; 2006 Nov; 18(11):2041-8. PubMed ID: 16725311
[TBL] [Abstract][Full Text] [Related]
5. Genome-wide mapping of RELA(p65) binding identifies E2F1 as a transcriptional activator recruited by NF-kappaB upon TLR4 activation.
Lim CA; Yao F; Wong JJ; George J; Xu H; Chiu KP; Sung WK; Lipovich L; Vega VB; Chen J; Shahab A; Zhao XD; Hibberd M; Wei CL; Lim B; Ng HH; Ruan Y; Chin KC
Mol Cell; 2007 Aug; 27(4):622-35. PubMed ID: 17707233
[TBL] [Abstract][Full Text] [Related]
6. Early growth response protein 1 upregulation and nuclear translocation by 2'-benzoyloxycinnamaldehyde induces prostate cancer cell death.
Kang HS; Ock J; Lee HJ; Lee YJ; Kwon BM; Hong SH
Cancer Lett; 2013 Feb; 329(2):217-27. PubMed ID: 23178451
[TBL] [Abstract][Full Text] [Related]
7. Protein kinase Cdelta activates RelA/p65 and nuclear factor-kappaB signaling in response to tumor necrosis factor-alpha.
Lu ZG; Liu H; Yamaguchi T; Miki Y; Yoshida K
Cancer Res; 2009 Jul; 69(14):5927-35. PubMed ID: 19549902
[TBL] [Abstract][Full Text] [Related]
8. Acute loss of transcription factor E2F1 induces mitochondrial biogenesis in HeLa cells.
Goto Y; Hayashi R; Kang D; Yoshida K
J Cell Physiol; 2006 Dec; 209(3):923-34. PubMed ID: 16972274
[TBL] [Abstract][Full Text] [Related]
9. Effect of Akt inhibition on scatter factor-regulated gene expression in DU-145 human prostate cancer cells.
Xu J; Gao M; Fan S; Meng Q; Goldberg ID; Abounader R; Ressom H; Laterra JJ; Rosen EM
Oncogene; 2007 May; 26(20):2925-38. PubMed ID: 17099727
[TBL] [Abstract][Full Text] [Related]
10. Growth and survival mechanisms associated with perineural invasion in prostate cancer.
Ayala GE; Dai H; Ittmann M; Li R; Powell M; Frolov A; Wheeler TM; Thompson TC; Rowley D
Cancer Res; 2004 Sep; 64(17):6082-90. PubMed ID: 15342391
[TBL] [Abstract][Full Text] [Related]
11. Genistein down-regulates the constitutive activation of nuclear factor-kappaB in human multiple myeloma cells, leading to suppression of proliferation and induction of apoptosis.
He H; Chen L; Zhai M; Chen JZ
Phytother Res; 2009 Jun; 23(6):868-73. PubMed ID: 19107739
[TBL] [Abstract][Full Text] [Related]
12. The tumor suppressor maspin mediates E2F1-induced sensitivity of cancer cells to chemotherapy.
Ben Shachar B; Feldstein O; Hacohen D; Ginsberg D
Mol Cancer Res; 2010 Mar; 8(3):363-72. PubMed ID: 20197383
[TBL] [Abstract][Full Text] [Related]
13. Identification of E1AF as a target gene of E2F1-induced apoptosis in response to DNA damage.
Wei Y; Liu D; Ge Y; Zhou F; Xu J; Chen H; Gu J; Jiang J
J Biochem; 2008 Oct; 144(4):539-46. PubMed ID: 18687701
[TBL] [Abstract][Full Text] [Related]
14. Interactions between E2F1 and SirT1 regulate apoptotic response to DNA damage.
Wang C; Chen L; Hou X; Li Z; Kabra N; Ma Y; Nemoto S; Finkel T; Gu W; Cress WD; Chen J
Nat Cell Biol; 2006 Sep; 8(9):1025-31. PubMed ID: 16892051
[TBL] [Abstract][Full Text] [Related]
15. Radiation-induced caspase-8 mediates p53-independent apoptosis in glioma cells.
Afshar G; Jelluma N; Yang X; Basila D; Arvold ND; Karlsson A; Yount GL; Dansen TB; Koller E; Haas-Kogan DA
Cancer Res; 2006 Apr; 66(8):4223-32. PubMed ID: 16618745
[TBL] [Abstract][Full Text] [Related]
16. Proteomic analysis of the E2F1 response in p53-negative cancer cells: new aspects in the regulation of cell survival and death.
Li Z; Kreutzer M; Mikkat S; Mise N; Glocker MO; Pützer BM
Proteomics; 2006 Nov; 6(21):5735-45. PubMed ID: 17001603
[TBL] [Abstract][Full Text] [Related]
17. The tumor suppressor gene hypermethylated in cancer 1 is transcriptionally regulated by E2F1.
Jenal M; Trinh E; Britschgi C; Britschgi A; Roh V; Vorburger SA; Tobler A; Leprince D; Fey MF; Helin K; Tschan MP
Mol Cancer Res; 2009 Jun; 7(6):916-22. PubMed ID: 19491197
[TBL] [Abstract][Full Text] [Related]
18. Antitumor effects of dehydroxymethylepoxyquinomicin, a novel nuclear factor-kappaB inhibitor, in human liver cancer cells are mediated through a reactive oxygen species-dependent mechanism.
Lampiasi N; Azzolina A; D'Alessandro N; Umezawa K; McCubrey JA; Montalto G; Cervello M
Mol Pharmacol; 2009 Aug; 76(2):290-300. PubMed ID: 19461054
[TBL] [Abstract][Full Text] [Related]
19. Translating DNA damage into cancer cell death-A roadmap for E2F1 apoptotic signalling and opportunities for new drug combinations to overcome chemoresistance.
Engelmann D; Pützer BM
Drug Resist Updat; 2010; 13(4-5):119-31. PubMed ID: 20675184
[TBL] [Abstract][Full Text] [Related]
20. Brain-derived neurotrophic factor protects cementoblasts from serum starvation-induced cell death.
Kajiya M; Shiba H; Fujita T; Takeda K; Uchida Y; Kawaguchi H; Kitagawa M; Takata T; Kurihara H
J Cell Physiol; 2009 Dec; 221(3):696-706. PubMed ID: 19711359
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
